Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurobiology of Aging

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2016.08.020PMID 27676333PMCID PMC5159317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory

  2016cited by this paper
• Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

  2016cited by this paper
• Therapeutic strategies for Alzheimer’s disease in clinical trials

  2016cited by this paper
• CREB expression mediates amyloid β-induced basal BDNF downregulation.

  2015influential reference
• Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials

  2015cited by this paper
• Calcitonin gene‐related peptide regulation of glial cell‐line derived neurotrophic factor in differentiated rat myotubes

  2015cited by this paper
• Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.

  2015cited by this paper
• Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.

  2015cited by this paper
• Huntington's disease is a four-repeat tauopathy with tau nuclear rods

  2014cited by this paper
• Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.

  2014cited by this paper
• Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease

  2014cited by this paper
• BDNF signaling and survival of striatal neurons

  2014cited by this paper
• Stable Mutated tau441 Transfected SH-SY5Y Cells as Screening Tool for Alzheimer’s Disease Drug Candidates

  2012cited by this paper
• Soluble forms of tau are toxic in Alzheimer’s disease

  2012cited by this paper
• Object recognition memory and BDNF expression are reduced in young TgCRND8 mice.

  2012cited by this paper
• Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.

  2012cited by this paper
• Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

  2012cited by this paper
• Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.

  2012cited by this paper
• The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target

  2012cited by this paper
• Pathogenesis of the Tauopathies

  2011cited by this paper
• Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons

  2011cited by this paper
• Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease.

  2011cited by this paper
• Identification of cis-Elements and Transcription Factors Regulating Neuronal Activity-Dependent Transcription of Human BDNF Gene

  2011cited by this paper
• BDNF Gene Polymorphisms are Associated with Alzheimer's Disease-Related Depression and Antidepressant Response

  2011cited by this paper
• The Neurotrophins and Their Role in Alzheimer’s Disease

  2011cited by this paper
• Brain-derived neurotrophic factor: the link between amyloid-β and memory loss

  2011cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Tau protein: relevance to Parkinson's disease.

  2010cited by this paper
• Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

  2010cited by this paper
• Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease.

  2009cited by this paper
• Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease

  2009cited by this paper
• Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology

  2009cited by this paper
• The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy

  2008cited by this paper
• Conditionally inducible tau mice – designing a better mouse model of neurodegenerative diseases

  2008cited by this paper
• Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains

  2007cited by this paper
• RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease

  2007cited by this paper
• The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy*

  2007cited by this paper
• Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

  2007cited by this paper
• Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

  2007cited by this paper
• Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells

  2007influential reference
• Role of brain-derived neurotrophic factor in Huntington's disease.

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Single molecule profiling of tau gene expression in Alzheimer’s disease

  2007cited by this paper
• Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters

  2007cited by this paper
• TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease

  2007cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Shift in the ratio of three‐repeat tau and four‐repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease

  2006cited by this paper
• Generalized, Linear, and Mixed Models

  2005cited by this paper
• Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease

  2005cited by this paper
• Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms

  2005cited by this paper
• Different tau epitopes define Aβ42-mediated tau insolubility

  2005cited by this paper
• Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta

  2005cited by this paper
• Different tau epitopes define Abeta42-mediated tau insolubility.

  2005cited by this paper
• Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics

  2004cited by this paper
• Brain-derived neurotrophic factor.

  2004cited by this paper
• Tau Protein and Neurodegeneration

  2004cited by this paper
• Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor.

  2004cited by this paper
• Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor

  2004cited by this paper
• β-Amyloid Peptide at Sublethal Concentrations Downregulates Brain-Derived Neurotrophic Factor Functions in Cultured Cortical Neurons

  2004cited by this paper
• Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

  2003cited by this paper
• Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition

  2003cited by this paper
• Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms

  2003cited by this paper
• Microtubule-associated tau protein positive neuronal and glial inclusions in ALS

  2003cited by this paper
• BDNF and activity-dependent synaptic modulation.

  2003cited by this paper
• Tau is essential to beta -amyloid-induced neurotoxicity.

  2002cited by this paper
• A new brain‐derived neurotrophic factor transcript and decrease inbrain‐derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex

  2002cited by this paper
• Tau is essential to β-amyloid-induced neurotoxicity

  2002cited by this paper
• Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

  2001cited by this paper
• Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

  2001cited by this paper
• Neurotrophins are required for nerve growth during development

  2001cited by this paper
• Neurofibrillary Pathology in Transgenic Mice Overexpressing V717F β‐Amyloid Precursor Protein

  2001cited by this paper
• Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles

  2001cited by this paper
• Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

  2001cited by this paper
• Tau and transgenic animal models.

  2001cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease

  2001cited by this paper
• Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes.

  2000cited by this paper
• Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

  2000cited by this paper
• Tau pathology: a marker of neurodegenerative disorders

  2000cited by this paper
• Abnormal tau-containing filaments in neurodegenerative diseases.

  2000cited by this paper
• Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.

  2000cited by this paper
• Brain-derived neurotrophic factor in Huntington disease.

  2000cited by this paper
• Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.

  2000cited by this paper
• Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

  2000cited by this paper
• Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

  1999cited by this paper
• Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.

  1999cited by this paper
• Memory and mental status correlates of modified Braak staging.

  1999cited by this paper
• Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

  1998cited by this paper
• Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Identification of a signaling pathway involved in calcium regulation of BDNF expression.

  1998cited by this paper
• Brain-derived neurotrophic factor is reduced in Alzheimer's disease.

  1997cited by this paper
• Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases

  1997cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Anterograde transport of brain-derived neurotrophic factor and its role in the brain

  1997cited by this paper

• Unraveling the molecular links: Alzheimer's disease-induced mechanisms of memory impairment: A narrative review

  2026cites this paper
• Application of Neurotrophic Factors as a Therapeutic Approach for Neurodegenerative Diseases

  2025cites this paper
• Muscle-brain crosstalk as a driver of brain health in aging.

  2025cites this paper
• Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease

  2025cites this paper
• Memory-Associated Immediate Early Genes: Roles in Synaptic Function, Memory Processes, and Neurological Diseases

  2025cites this paper
• Tyrosine and Phenylalanine Activate Neuronal DNA Repair but Exhibit Opposing Effects on Global Transcription and Adult Female Mice Are Resilient to TyrRS/YARS1 Depletion

  2025cites this paper
• Physical activity in Alzheimer's disease prevention: Sex differences and the roles of BDNF and irisin.

  2025cites this paper
• Neurotrophic factor alpha 1 gene therapy in Alzheimer’s disease: scope and advancements

  2025cites this paper
• Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.

  2025cites this paper
• Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology

  2025cites this paper
• Relationship between brain-derived neurotrophic factor and tropomyosin kinase receptor type B gene polymorphisms with cerebrospinal fluid visinin-like protein 1 levels in Alzheimer’s disease

  2025cites this paper
• Novel peptidomimetic compounds attenuate hypoxic-ischemic brain injury in neonatal rats.

  2025cites this paper
• The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease

  2025cites this paper
• Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models

  2024cites this paper
• Effects of Ficus exasperata on neurotransmission and expression of BDNF, tau, ACHE and BACE in diabetic rats

  2024cites this paper
• Efficacy and safety of prophylactic use of benzhexol after risperidone treatment in MK-801-induced mouse model of schizophrenia

  2024cites this paper
• Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases

  2024cites this paper
• A Combined Computational and Experimental Approach to Studying Tropomyosin Kinase Receptor B Binders for Potential Treatment of Neurodegenerative Diseases

  2024cites this paper
• Temporal progression of tau pathology and neuroinflammation in a rhesus monkey model of Alzheimer's disease

  2024cites this paper
• Regulatory Role of NF-κB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin.

  2024cites this paper
• Along the microbiota-gut-brain axis: Use of plant polysaccharides to improve mental disorders.

  2024cites this paper
• Association of Neurotrophic Factors at Midlife With In Vivo Measures of β-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults

  2024cites this paper
• BDNF Val66Met moderates episodic memory decline and tau biomarker increases in early sporadic Alzheimer’s disease

  2024cites this paper
• Anti-Alzheimer potential of Solanum lycopersicum seeds: in vitro, in vivo, metabolomic, and computational investigations

  2024cites this paper
• Neurotrophins and Other Growth Factors in the Pathogenesis of Alzheimer’s Disease

  2023influential citation
• Tau Accumulation in the Spinal Cord Contributes to Chronic Inflammatory Pain by Upregulation of IL-1β and BDNF

  2023cites this paper
• Neuroprotective effect of whey protein hydrolysate containing LDIQK on HT22 cells in hydrogen peroxide-induced oxidative stress.

  2023cites this paper
• Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer’s Disease

  2023cites this paper
• Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor

  2023cites this paper
• Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite Pathology

  2023cites this paper
• Abelmoschus eculentus Seed Extract Exhibits In Vitro and In Vivo Anti-Alzheimer’s Potential Supported by Metabolomic and Computational Investigation

  2023cites this paper
• Notopterol improves cognitive dysfunction and depression-like behavior via inhibiting STAT3/NF-ĸB pathway mediated inflammation in glioma-bearing mice.

  2023cites this paper
• Using ΔK280 TauRD Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy

  2023cites this paper
• Introducing BDNF and SNAI1 as the Crucial Targeted Genes by UV Radiation.

  2022cites this paper
• Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B.

  2022cites this paper
• Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential

  2022cites this paper
• Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease.

  2022cites this paper
• Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer’s Disease

  2022cites this paper
• Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases

  2022cites this paper
• The Role of Brain-Derived Neurotrophic Factor Signaling in Central Nervous System Disease Pathogenesis

  2022cites this paper
• The role of brain derived neurotrophic factor in central nervous system

  2022cites this paper
• Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein

  2022cites this paper
• The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives

  2022cites this paper
• Minocycline Attenuates Lipopolysaccharide-Induced Locomotor Deficit and Anxiety-like Behavior and Related Expression of the BDNF/CREB Protein in the Rat Medial Prefrontal Cortex (mPFC)

  2022cites this paper
• Minocycline attenuates lipopolysaccharide-induced locomotor de�cit and anxiety-like behavior via upregulation of the BDNF/CREB protein expression in the rat medial prefrontal cortex (mPFC)

  2022cites this paper
• Induction of Oxidative Stress in SH-SY5Y Cells by Overexpression of hTau40 and Its Mitigation by Redox-Active Nanoparticles

  2022cites this paper
• Euonymus alatus Twig Extract Protects against Scopolamine-Induced Changes in Brain and Brain-Derived Cells via Cholinergic and BDNF Pathways

  2022cites this paper
• Therapeutic potential of neurotrophic factors in Alzheimer’s Disease

  2021cites this paper
• Mesenchymal stem cells after the proprocessing of tanshinone IIA attenuate cognitive deficits and oxidative stress injury in an amyloid β-peptide (25–35)-induced rodent model of Alzheimer’s disease

  2021cites this paper
• Brain-Derived Neurotrophic Factor Signaling in the Pathophysiology of Alzheimer’s Disease: Beneficial Effects of Flavonoids for Neuroprotection

  2021cites this paper
• Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer’s Disease

  2021cites this paper
• DNT1 Downregulation and Increased Ethanol Sensitivity in Transgenic Drosophila Models of Alzheimer's Disease.

  2021cites this paper
• Cholinergic neurodegeneration in Alzheimer disease mouse models.

  2021cites this paper
• Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease

  2021cites this paper
• Novel Synthetic Coumarin-Chalcone Derivative (E)-3-(3-(4-(Dimethylamino)Phenyl)Acryloyl)-4-Hydroxy-2H-Chromen-2-One Activates CREB-Mediated Neuroprotection in Aβ and Tau Cell Models of Alzheimer's Disease

  2021cites this paper
• Targeting Brain-Derived Neurotrophic Factor (BDNF) - An Important Strategy to Alzheimer's Disease

  2021cites this paper
• BDNF VAL66MET polymorphism and memory decline across the spectrum of Alzheimer's disease

  2020cites this paper
• Challenges of BDNF-based therapies: from common to rare diseases.

  2020cites this paper
• Anxiolytic, antioxidant, and neuroprotective effects of goji berry polysaccharides in ovariectomized rats: experimental evidence from behavioral, biochemical, and immunohistochemical analyses

  2020cites this paper
• Dysregulation of prostaglandine E2 and BDNF signaling mediated by estrogenic dysfunction induces primary hippocampal neuronal cell death after single and repeated paraquat treatment.

  2020cites this paper
• Neuroprotective Brain-Derived Neurotrophic Factor signaling in the TAU-P301L tauopathy zebrafish model.

  2020cites this paper
• Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD mice

  2020cites this paper
• Differential Effects of Chronic Immunosuppression on Behavioral, Epigenetic and Alzheimer’s Disease- Associated Markers in 3xTg-AD Mice

  2020cites this paper
• A narrative review of brain-derived neurotrophic factor (BDNF) on cognitive performance in Alzheimer’s disease

  2020cites this paper
• Adeno‐associated virus‐based Alzheimer's disease mouse models and potential new therapeutic avenues

  2019cites this paper
• Isorhamnetin enhanced cortico-hippocampal learning and memory capability in mice with scopolamine-induced amnesia: Role of antioxidant defense, cholinergic and BDNF signaling.

  2019cites this paper
• The effects of aminoguanidine on hippocampal cytokines, amyloid beta, brain‐derived neurotrophic factor, memory and oxidative stress status in chronically lipopolysaccharide‐treated rats

  2019cites this paper
• The effects of PPAR-γ agonist pioglitazone on hippocampal cytokines, brain-derived neurotrophic factor, memory impairment, and oxidative stress status in lipopolysaccharide-treated rats

  2019cites this paper
• Metformin alleviates neuronal and renal related stress signals in diabetic C57BL/6 mice.

  2019influential citation
• Nerve Growth Factor Pathobiology During the Progression of Alzheimer’s Disease

  2019cites this paper
• Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways

  2019cites this paper
• Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer’s disease pathologies

  2019cites this paper
• Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease.

  2019cites this paper
• Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain

  2019cites this paper
• Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

  2019cites this paper
• Streptozotocin causes acute responses on hippocampal S100B and BDNF proteins linked to glucose metabolism alterations.

  2019cites this paper
• The role of MAPK signaling pathway in selenium amelioration of high fat/high cholesterol diet-induced tauopathy in rats.

  2019cites this paper
• Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease

  2018cites this paper
• Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice

  2018cites this paper
• Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits

  2018cites this paper
• MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor

  2018cites this paper
• GPR30 activation improves memory and facilitates DHPG‐induced LTD in the hippocampal CA3 of middle‐aged mice

  2018cites this paper
• Effect of BDNF Val66Met on disease markers in dominantly inherited AD

  2018cites this paper
• The effect of CA1 administration of orexin-A on hippocampal expression of COX-2 and BDNF in a rat model of orofacial pain

  2018cites this paper
• The Role of Brain-Derived Neurotrophic Factor in the Pathophysiology of Psychiatric and Neurological Disorders

  2017influential citation
• Lactuca capensis reverses memory deficits in Aβ1‐42‐induced an animal model of Alzheimer's disease

  2017cites this paper
• Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease

  2017cites this paper